Results 281 to 290 of about 250,417 (383)

Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita? [PDF]

Curr Obes Rep
Argyrakopoulou G, Gitsi E, Dalamaga M, Kokkinos A.   +3 more
europepmc   +1 more source

A Case of Factitious Hypoglycemia Induced by Self-Administration of Sulfonylurea

, 1978
Kenji Shima, Ryoichi Tanaka, Jiro Nakamura, Yoshiaki Okada, Y Kumahara   +4 more
openalex   +2 more sources

Dextromethorphan versus Dextrorphan: A Quantitative Comparison of Antitussive Potency following Separate Administration of Metabolite

The Journal of Clinical Pharmacology, EarlyView.
Abstract To assess the antitussive effects of dextrorphan (DOR) relative to its parent compound, dextromethorphan (DEX) a double‐blind, randomized, placebo‐controlled crossover study was conducted in 23 healthy volunteers using citric acid cough challenge test after administering placebo, DEX, or DOR.
Saeed Rezaee, Caroline E. Wright, Alyn H. Morice, Amin Rostami‐Hodjegan   +3 more
wiley   +1 more source

Causal Relationship Between Various Vitamins and Different Diabetic Complications: A Mendelian Randomization Study. [PDF]

Food Sci Nutr
Cai S, Man W, Liu W, Li B, He Z, Duan G.
europepmc   +1 more source

Neonatal Hypoglycemia Following Diet-Controlled and Insulin-Treated Gestational Diabetes Mellitus

Diabetes Care, 2018
D. Voormolen, L. de Wit, B. V. van Rijn, J. DeVries, M. P. Heringa, A. Franx, F. Groenendaal, Marije Lamain-de Ruiter   +7 more
semanticscholar   +1 more source

Intranasal Naloxone During Recurrent Exercise in Individuals with Type‐1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure–Response

The Journal of Clinical Pharmacology, EarlyView.
Abstract Impaired awareness of hypoglycemia (IAH) impacts 25%–30% of individuals with type 1 diabetes mellitus (T1D), potentially leading to severe outcomes due to reduced symptom perception. Naloxone, a mu‐opioid receptor antagonist, shows promise as a preventive measure against IAH.
Omar N. Al Yacoub, Shen Cheng, Mohamed S. Fayed, James Fisher, Jillian Brooks, Elizabeth Seaquist, Anjali Kumar, Amir Moheet, Lynn Eberly, Lisa D. Coles   +9 more
wiley   +1 more source

Severe and Prolonged Hypoglycemia Following Adrenalectomy for Pheochromocytoma: A Case Report. [PDF]

Cureus
Kawasumi M, Sakamoto Y, Tosaka Y, Okazaki Y, Furuya S.   +4 more
europepmc   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

The Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick, Colin Berry, Meredith A. Carpenter, Geeta Gulati, Siri Lagethon Heck, Michael A. Hinterberg, Rury R. Holman, Matthew M.Y. Lee, Torbjørn Omland, Clare Paterson, Mark C. Petrie, Naveed Sattar, Svati H. Shah, Sama Shrestha, Harald Sourij, Emma V Troth, Victoria Vinje, Stephen A. Williams   +17 more
wiley   +1 more source

Evaluating the Potential of Prevalent New User Design as an Alternative When New User Design is Impractical. [PDF]

Pragmat Obs Res
Koinuma T, Akazawa M.
europepmc   +1 more source